Orient Pharma Price To Book vs. Shares Outstanding

4166 Stock  TWD 36.55  0.45  1.22%   
Based on the key profitability measurements obtained from Orient Pharma's financial statements, Orient Pharma Co may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Orient Pharma's ability to earn profits and add value for shareholders.
For Orient Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Orient Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Orient Pharma Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Orient Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Orient Pharma Co over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Orient Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Orient Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orient Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Orient Pharma Shares Outstanding vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Orient Pharma's current stock value. Our valuation model uses many indicators to compare Orient Pharma value to that of its competitors to determine the firm's financial worth.
Orient Pharma Co is rated third in price to book category among its peers. It is rated second in shares outstanding category among its peers creating about  56,937,956  of Shares Outstanding per Price To Book. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Orient Pharma's earnings, one of the primary drivers of an investment's value.

Orient Shares Outstanding vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Orient Pharma

P/B

 = 

MV Per Share

BV Per Share

 = 
2.74 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Orient Pharma

Shares Outstanding

 = 

Public Shares

-

Repurchased

 = 
156.01 M
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

Orient Shares Outstanding Comparison

Orient Pharma is number one stock in shares outstanding category among its peers.

Orient Pharma Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Orient Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Orient Pharma will eventually generate negative long term returns. The profitability progress is the general direction of Orient Pharma's change in net profit over the period of time. It can combine multiple indicators of Orient Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Orient Pharma Co., Ltd. researches, develops, manufactures, and sells drugs in Taiwan and internationally. Orient Pharma Co., Ltd. is a subsidiary of Orient Europharma Co., Ltd. ORIENT PHARMA operates under Drug Manufacturers - Major classification in Taiwan and is traded on Taiwan OTC Exchange.

Orient Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Orient Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Orient Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Orient Pharma's important profitability drivers and their relationship over time.

Use Orient Pharma in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Orient Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orient Pharma will appreciate offsetting losses from the drop in the long position's value.

Orient Pharma Pair Trading

Orient Pharma Co Pair Trading Analysis

The ability to find closely correlated positions to Orient Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Orient Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Orient Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Orient Pharma Co to buy it.
The correlation of Orient Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Orient Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Orient Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Orient Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Orient Pharma position

In addition to having Orient Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Plastics Thematic Idea Now

Plastics
Plastics Theme
Companies manufacturing rubber and plastics accessories. The Plastics theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Plastics Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Orient Stock Analysis

When running Orient Pharma's price analysis, check to measure Orient Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orient Pharma is operating at the current time. Most of Orient Pharma's value examination focuses on studying past and present price action to predict the probability of Orient Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orient Pharma's price. Additionally, you may evaluate how the addition of Orient Pharma to your portfolios can decrease your overall portfolio volatility.